November 8, 2024 03:09 PM EST
Pharma
FDA+
Manufacturing

FDA records re­quest lands Chi­nese API man­u­fac­tur­er on blocked im­port list

Zachary Brennan

Senior Editor

The FDA this week post­ed an un­ti­tled let­ter sent Oct. 17 to Chi­na-based ac­tive phar­ma­ceu­ti­cal in­gre­di­ent (API) man­u­fac­tur­er Shan­dong Boyuan Phar­ma­ceu­ti­cal Co., whose ex­ports to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

NewAms­ter­dam aces Phase 3 tri­al, but in­vestors are skep­ti­cal

Pfiz­er part­ners with two more Flag­ship biotechs on obe­si­ty, can­cer

Post-Hoc: RFK vs. Vivek, and the fu­ture of US drug pol­i­cy

FDA up­dates la­bel of 33-year-old can­cer drug with new dose and warn­ing

Car­olyn Bertozzi’s lat­est biotech de­buts with $30M seed round and a sug­ary spin on im­munother­a­py

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times